We determined the ferrophilic characteristics of Vibrio vulnificus to evaluate the potential usefulness of iron chelation therapy for the prevention of V. vulnificus infection. Readily available non-transferrin-bound iron (NTBI) is required for the initiation of V. vulnificus growth under in vitro iron-limited conditions and human ex vivo conditions. NTBI aided efficient transferrin-bound iron (TBI) use by V. vulnificus, and the vulnibactin-mediated iron-uptake system was expressed after bacterial growth had been started by NTBI. V. vulnificus required higher NTBI levels for the initiation of growth, produced siderophores at lower levels, and used TBI less efficiently than other bacteria. In addition, the growth of V. vulnificus was inhibited by deferiprone, a clinically available iron chelator. These results show that V. vulnificus is a ferrophilic bacterium that requires higher NTBI levels than other pathogens and that iron chelation therapy might be an effective means of preventing the in vivo growth of V. vulnificus in susceptible patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1086/509822 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Atomically dispersed rare earth dysprosium-nitrogen-carbon for boosting oxygen reduction reaction.
J Colloid Interface Sci
January 2025
Collaborative Innovation Center of Sustainable Energy Materials, School of Physical Science and Technology, Guangxi University, Guangxi Key Laboratory of Electrochemical Energy Materials, State Key Laboratory of Featured Metal Materials and Life-cycle Safety for Composite Structures, Nanning 530004, China. Electronic address:
Transition metal-nitrogen-carbon (MNC) based on 3d metal atoms as promising non-precious metal catalysts have been extensively exploited for oxygen reduction reaction (ORR), but MNC with 4f rare earth metals have been largely ignored, most likely due to their large atomic radii that are difficult to coordinate with N dopants using conventional precursors. Herein, atomically dispersed dysprosium-nitrogen-carbon (DyNC) nanosheets were developed via the pyrolysis of anitrogen-containing chelate compound of 2, 4, 6-Tri (2-pyridyl) 1, 3, 5-triazine (TPTZ) ligand with Dy under the assistance of molten NaCl. The as-synthesized DyNC features specific moieties of single Dy atom coordinated by N and O as active sites for ORR, displaying excellent performance.
View Article and Find Full Text PDFMetal-Catalyzed Abiotic Cleavage of C═C Bonds for Effective Fluorescence Imaging of Cu(II) and Fe(III) in Living Systems.
Adv Sci (Weinh)
January 2025
Faculty of Health Sciences, University of Macau, Macau SAR, 999078, China.
Imaging abnormal copper/iron with effective fluorescent tools is essential to comprehensively put insight into many pathological events. However, conventional coordination-based detection is mired in the fluorescence quenching induced by paramagnetic Cu(II)/Fe(III). Moreover, the strong chelating property of the probe will consume dissociative metal ions and inevitably interfere with the physiological microenvironment.
View Article and Find Full Text PDFDeveloping Topics.
Alzheimers Dement
December 2024
USC Leonard Davis School of Gerontology, Los Angeles, CA, USA.
Background: Iron is implicated in Alzheimer's disease (AD) and is bound to β-amyloid (Ab) plaques. AD brains have increased 4-hydroxynonenal (HNE) adducts, a lipid decomposition product bound to proteins originating from iron mediated lipid peroxidation. Increased brain iron may result from cerebral microbleeds which by nature are rich sources of iron.
View Article and Find Full Text PDFDrug Development.
Alzheimers Dement
December 2024
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Australia, Melbourne, VIC, Australia.
Background: Iron is vital for metabolism but can act as a catalyst for oxidative damage. Elevated brain iron, determined from biomarkers of iron (CSF ferritin and quantitative susceptibility mapping MRI) and from post-mortem measurement of brain iron, has been associated with accelerated cognitive decline in multiple Alzheimer's disease (AD) clinical, cohorts. These findings supported the hypothesis that treatment with the brain-permeable iron chelator deferiprone may be associated clinical benefit in AD.
View Article and Find Full Text PDFDeciphering the δ-Lactam Formation and lron-Reducing Activity of Spinactins from .
Org Lett
January 2025
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
The cyclic structure of non-ribosomal peptides (NRPs) is critical for enhancing their stability and bioactivity, which highlights the importance of exploring NRP cyclization enzymes for natural product discovery. Thioesterases (TEs) are crucial enzymes that catalyze the formation of various lactams, including macrolactams, β-lactams, and γ-lactams; however, their potential to produce other lactam types remains largely unexplored. In this study, we identified spinactin A () and novel derivatives, spinactin B-E (-), from NRRL 18395 and characterized the biosynthetic enzymes involved, particularly a unique TE SncF, responsible for δ-lactam formation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!